Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment
about
Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadCost Effectiveness of Influenza Vaccine Choices in Children Aged 2-8 Years in the U.S.Potential Consequences of Not Using Live Attenuated Influenza Vaccine.Cost Effectiveness of Influenza Vaccine for U.S. Children: Live Attenuated and Inactivated Influenza VaccineDevelopment of a stable liquid formulation of live attenuated influenza vaccine.
P2860
Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Vaccination of children with a ...... a Health Technology Assessment
@ast
Vaccination of children with a ...... a Health Technology Assessment
@en
Vaccination of children with a ...... a Health Technology Assessment
@nl
type
label
Vaccination of children with a ...... a Health Technology Assessment
@ast
Vaccination of children with a ...... a Health Technology Assessment
@en
Vaccination of children with a ...... a Health Technology Assessment
@nl
prefLabel
Vaccination of children with a ...... a Health Technology Assessment
@ast
Vaccination of children with a ...... a Health Technology Assessment
@en
Vaccination of children with a ...... a Health Technology Assessment
@nl
P2093
P2860
P356
P1476
Vaccination of children with a ...... a Health Technology Assessment
@en
P2093
Frank Andersohn
Martin Frank
Oliver Damm
Reinhard Bornemann
Thomas Mittendorf
Ulrike Theidel
P2860
P356
10.3205/HTA000119
P577
2014-10-30T00:00:00Z